Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
Completed
Conditions studied: Cancer
In brief
The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
Key facts
- Study ID
- NCT00322634
- Run by
- New Mexico Cancer Research Alliance
- People needed
- 25
- Starts
- 2006-02-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2012-09-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients must be at least 18 years of age
- All patients must have documented incurable metastatic cancer
- All patients must have exhausted any treatments which are known to prolong survival in their disease, or have elected not to receive further life-prolonging therapy. Specifically, patients with the following are eligible:
- Non-small cell lung cancer patients after third systemic therapy
- Small cell lung cancer patients after second systemic therapy
- Breast cancer patients after third cytotoxic therapy (does not include hormonal therapy)
- Colorectal cancer patients after second systemic therapy
- Hormone refractory prostate cancer patients after first cytotoxic therapy
- Cancer of unknown primary
- Pancreatic cancer patients after first systemic therapy
- The use of systemic (chemotherapy, immunotherapy) or local treatments (XRT) for palliation of symptoms is allowed
- Patients with a history of previous cancers are allowed
- Patients with a history of other significant disease (e.g. heart disease, COPD, etc.) are allowed
- All patients must sign informed consent
You may not qualify if…
- Patients with acute or chronic leukemia, Hodgkin's disease, or non-Hodgkins lymphoma are excluded
- Patients who do not sign informed consent are excluded
Where it is running
- Hematology Oncology Associates — Albuquerque, New Mexico, United States
- Radiation Oncology Associates — Albuquerque, New Mexico, United States
- University of New Mexico — Albuquerque, New Mexico, United States
- New Mexico Cancer Care Associates — Santa Fe, New Mexico, United States
- St. Vincent Regional Medical Center — Santa Fe, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.